Debbie L Cohen
Debbie L Cohen is an expert in Cardiology at Hospital of the University of Pennsylvania (United States). As of October 2026, ScienceLeadR ranks Debbie L Cohen in the top 1% of experts worldwide for Hypertension. Debbie L Cohen has authored 371 publications, the most recent in 2026, and is an investigator in 16 clinical trials, 2 of them ongoing. SLR score: 1,128 (community average: 125). How the SLR is computed.
LeadR Profile
Cardiology
Subspecialties: Nephrology - Urology - Endocrinology
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 2001 - 2026
Number : 371
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| KDOQI Commentary on the 2025 AHA/ACC Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. PMID 42907045 — kidney diseases, hypertension, blood, blood pressure, kidney, work | Am J Kidney Dis | 2026 | 0 |
| Aldosterone-Producing Lesions Harboring ATP1A1 and ATP2B3 Mutations: An International Multicenter Study. PMID 42866865 — adrenal cortex, hypertension, aldosterone, adrenal glands, phenotype, hyperaldosteronism, steroids, wounds and injuries, mutation, hemodynamics, adrenal gland neoplasms | Hypertension | 2026 | 0 |
| Association of visit-to-visit blood pressure variability with kidney disease progression and cardiovascular outcomes in the chronic renal insufficiency cohort (CRIC). PMID 42695457 — kidney diseases, hypertension, blood, cardiovascular diseases, disease progression, blood pressure, kidney, renal insufficiency, renal insufficiency, chronic | J Hypertens | 2026 | 0 |
| Proteinuria and Kidney Function Trajectories in Patients with Advanced CKD: Insights from CRIC and KNOW-CKD Studies. PMID 42658641 — kidney diseases, proteinuria, creatinine, kidney, nephrology | Clin J Am Soc Nephrol | 2026 | 0 |
| Risk Reclassification Beyond BMI by Waist Circumference and Waist-to-Hip Ratio Across 9 Cardiovascular Outcomes: Results From the Cross-Cohort Collaboration. PMID 42583989 — waist-hip ratio, mortality, heart diseases, heart failure, heart, cardiovascular diseases, atrial fibrillation, adiposity, obesity, coronary disease, overweight, waist circumference | J Am Coll Cardiol | 2026 | 6 |
Clinical Studies 16
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Cohort/Consortium Investigators 63
Ongoing Clinical Trials
2 ongoing trials started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Metabolic Changes Associated With Weight Gain After Treatment of Achalasia NCT07334639 — esophageal achalasia, weight gain, liver, aftercare, obesity, therapeutics, fatty liver, metabolic syndrome | N/A | Not yet recruiting | 2026 |
| Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke NCT04760717 — cerebral hemorrhage, hemorrhage, blood, ischemic stroke, stroke, blood pressure, recycling, therapeutics, spironolactone | Phase 2 | Active not recruiting | 2021 |
LeadR Networks
Main global connection map